The Growing Genetic and Functional Diversity of Extended Spectrum Beta-Lactamases

BioMed Research International

Volumn 2018, Issue , 2018, Pages

  Ur Rahman, Sadeeq ^a,b   Ali, Tariq ^a   Ali, Ijaz ^c   Khan, Nazir Ahmad ^d   Han, Bo ^a   Gao, Jian ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b ABDUL WALI KHAN UNIVERSITY   (Pakistan)

^c Chak Shahzad Campus ^*  (Pakistan)

^d THE UNIVERSITY OF AGRICULTURE   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE CTX M; BETA LACTAMASE OXA; BETA LACTAMASE SHV; BETA LACTAMASE TEM 1; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CEPHEM DERIVATIVE; CLAVULANIC ACID; DORIPENEM; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; MEROPENEM; MONOBACTAM DERIVATIVE; PENICILLIN DERIVATIVE; PENICILLINASE; SULFONAMIDE; TETRACYCLINE; UNCLASSIFIED DRUG; BACTERIAL PROTEIN; BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; BACTERIAL GENE; BACTERIAL INFECTION; DRUG DEGRADATION; EPIDEMIOLOGICAL DATA; GENETIC VARIABILITY; GENOTYPE; HEREDITY; HUMAN; NONHUMAN; PROTEIN FUNCTION; REVIEW; BACTERIUM; BETA-LACTAM RESISTANCE; ENZYMOLOGY; GENETICS; METABOLISM;

BACTERIA; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CEPHALOSPORINS;

EID: 85045579571     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2018/9519718     Document Type: Review

References (100)

1. J. R. Piet, P. Van Ulsen, S. Ur Rahman et al., "Meningococcal two-partner secretion systems and their association with outcome in patients with meningitis, " Infection and Immunity, vol. 84, no. 9, pp. 2534-2540, 2016.
2. S. Ur Rahman, J. Arenas, H. öztürk, N. Dekker, and P. Van Ulsen, "The polypeptide transport-associated (POTRA) domains of TpsB transporters determine the system specificity of two-partner secretion systems, " The Journal of Biological Chemistry, vol. 289, no. 28, pp. 19799-19809, 2014.
3. S. Ur Rahman and P. van Ulsen, "Systemspecificity of the TpsB transporters of coexpressed two-partner secretion systems of Neisseria meningitidis, " Journal of Bacteriology, vol. 195, no. 4, pp. 788-797, 2013.
4. P. Van Ulsen, S. U. Rahman, W. S. P. Jong, M. H. Daleke-Schermerhorn, and J. Luirink, "Type V secretion: from biogenesis to biotechnology, " Biochimica et Biophysica Acta (BBA)-Molecular Cell Research, vol. 1843, no. 8, pp. 1592-1611, 2014.
5. A. J. Wright, "The penicillins, " Mayo Clinic Proceedings, vol. 74, no. 3, pp. 290-307, 1999.
6. B. H. Normark and S. Normark, "Evolution and spread of antibiotic resistance, " Journal of Internal Medicine, vol. 252, no. 2, pp. 91-106, 2002.
7. J. N. Samaha-Kfoury and G. F. Araj, "Recent developments in lactamases and extended spectrum lactamases, " British Medical Journal, vol. 327, no. 7425, pp. 1209-1213, 2003.
8. R. Finch, P. Davey, M. H. Wilcox, andW. Irving, Antimicrobial Chemotherapy, Oxford University Press, 2012.
9. E. P. Abraham and E. Chain, "An enzyme from bacteria able to destroy penicillin [1], " Nature, vol. 146, no. 3713, p. 837, 1940.
10. G.-Y. Tan, Y. Peng, C. Lu, L. Bai, and J.-J. Zhong, "Engineering validamycin production by tandem deletion of-butyrolactone receptor genes in Streptomyces hygroscopicus 5008, " Metabolic Engineering, vol. 28, pp. 74-81, 2015.
11. T.-C. Zhou and J.-J. Zhong, "Production of validamycin A from hemicellulose hydrolysate by Streptomyces hygroscopicus 5008, " Bioresource Technology, vol. 175, pp. 160-166, 2015.
12. M. Cizman, "The use and resistance to antibiotics in the community, " International Journal of Antimicrobial Agents, vol. 21, no. 4, pp. 297-307, 2003.
13. J. D. D. Pitout, C. C. Sanders, and W. E. Sanders Jr., "Antimicrobial resistance with focus on-lactam resistance in gramnegative bacilli, " American Journal of Medicine, vol. 103, no. 1, pp. 51-59, 1997.
14. G. A. Jacoby and L. S. Munoz-Price, "Thenew beta-lactamases, " The New England Journal of Medicine, vol. 352, no. 4, pp. 380-391, 2005.
15. T. Fosse, C. Giraud-Morin, I. Madinier, and R. Labia, "Sequence analysis and biochemical characterisation of chromosomal CAV-1 (Aeromonas caviae), the parental cephalosporinase of plasmid-mediated AmpC "FOX" cluster, " FEMS Microbiology Letters, vol. 222, no. 1, pp. 93-98, 2003.
16. M. B. Avison, P. Niumsup, T. R. Walsh, and P. M. Bennett, "Aeromonas hydrodphila AmpH and CepH-lactamases: derepressed expression in mutants of Escherichia coli lacking creB, " Journal of Antimicrobial Chemotherapy, vol. 46, no. 5, pp. 695-702, 2000.
17. B. A. Rasmussen, D. Keeney, Y. Yang, and K. Bush, "Cloning and expression of a cloxacillin-hydrolyzing enzyme and a cephalosporinase from Aeromonas sobria AER 14M in Escherichia coli: requirement for an E. coli chromosomal mutation for efficient expression of the class D enzyme, " AntimicrobialAgents and Chemotherapy, vol. 38, no. 9, pp. 2078-2085, 1994.
18. M. V. Hayes, C. J. Thomson, and S. G. B. Amyes, "Three betalactamases isolated from Aeromonas salmonicida, including a carbapenemase not detectable by conventional methods, " European Journal of Clinical Microbiology & Infectious Diseases, vol. 13, no. 10, pp. 805-811, 1994.
19. T. R. Walsh, L. Hall, A. P. Macgowan, and P. M. Bennett, "Sequence analysis of two chromosomally mediated inducible-lactamases from aeromonas sobria, strain 163a, one a class d penicillinase, the other an ampc cephalosporinase, " Journal of Antimicrobial Chemotherapy, vol. 36, no. 1, pp. 41-52, 1995.
20. V. Fihman, M. Rottman, Y. Benzerara et al., "BUT-1: A new member in the chromosomal inducible class C-lactamases family from a clinical isolate of Buttiauxella sp, " FEMS Microbiology Letters, vol. 213, no. 1, pp. 103-111, 2002.
21. T. Naas, D. Aubert, N. Fortineau, and P. Nordmann, "Cloning and sequencing of the-lactamase gene and surrounding DNA sequences of Citrobacter braakii, Citrobacter murliniae, Citrobacter werkmanii, Escherichia fergusonii and Enterobacter cancerogenus, " FEMS Microbiology Letters, vol. 215, no. 1, pp. 81-87, 2002.
22. F. Lindberg and S. Normark, "Sequence of the Citrobacter freundii OS60 chromosomal ampC-lactamase gene, " The FEBS Journal, vol. 156, no. 3, pp. 441-445, 1986.
23. M. B. Avison, S. Underwood, A. Okazaki, T. R. Walsh, and P. M. Bennett, "Analysis of AmpC-lactamase expression and sequence in biochemically atypical ceftazidime-resistant Enterobacteriaceae frompaediatric patients, " Journal ofAntimicrobial Chemotherapy, vol. 53, no. 4, pp. 584-591, 2004.
24. I. Stock and B. Wiedemann, "Natural antibiotic susceptibilities of Edwardsiella tarda, E. ictaluri, and E. hoshinae, " Antimicrobial Agents and Chemotherapy, vol. 45, no. 8, pp. 2245-2255, 2001.
25. D. Nadjar, R. Labia, C. Cerceau, C. Bizet, A. Philippon, and G. Arlet, "Molecular characterization of chromosomal class C-lactamase and its regulatory gene in Ochrobactrum anthropi, " AntimicrobialAgents and Chemotherapy, vol. 45, no. 8, pp. 2324-2330, 2001.
26. M. Rottman, Y. Benzerara, B. Hanau-Berçot, C. Bizet, A. Philippon, and G. Arlet, "Chromosomal ampC genes in Enterobacter species other than Enterobacter cloacae, and ancestral association of the ACT-1 plasmid-encoded cephalosporinase to Enterobacter asburiae, " FEMSMicrobiology Letters, vol. 210, no. 1, pp. 87-92, 2002.
27. M. Galleni, F. Lindberg, S. Normark et al., "Sequence and comparative analysis of three Enterobacter cloacae ampC betalactamase genes and their products., " Biochemical Journal, vol. 250, no. 3, pp. 753-760, 1988.
28. B. Jaurin and T. Grundstrom, "ampC cephalosporinase of Escherichia coli K-12 has a different evolutionary origin from that of-lactamases of the penicillinase type, " in Proceedings of theNational Acadamy of Sciences of theUnited States of America, vol. 78, pp. 4897-4901, 1981.
29. D. Girlich, T. Naas, S. Bellais, L. Popirel, A. Karim, and P. Nordmann, "Heterogeneity of AmpC cephalosporinase of Hafnia alvei clinical isolates expressing inducible or constitutive ceftazidime resistance phenotypes, " Antimicrobial Agents and Chemotherapy, vol. 44, no. 11, pp. 3220-3223, 2000.
30. L. Poirel, M. Guibert, D. Girlich, T. Naas, and P. Nordmann, "Cloning, sequence analyses, expression, and distribution of ampC-ampR from Morganella morganii clinical isolates, " Antimicrobial Agents and Chemotherapy, vol. 43, no. 4, pp. 769-776, 1999.
31. N. A. C. Curtis, R. L. Eisenstadt, C. Rudd, and A. J. White, "Inducible type i lactamases of gram-negative bacteria and resistance to -lactam antibiotics, " Journal of Antimicrobial Chemotherapy, vol. 17, no. 1, pp. 51-61, 1986.
32. B. Joris, F. de Meester, M. Galleni et al., "Properties of a class C-lactamase from Serratia marcescens, " Biochemical Journal, vol. 239, no. 3, pp. 581-586, 1986.
33. H. Schumacher, M. Nir, B. Mansa, andA. Grassy, "-lactamases in Shigella: brief report, " APMIS-Acta Pathologica, Microbiologica et Immunologica Scandinavica, vol. 100, no. 7-12, pp. 954-956, 1992.
34. A. Seoane, M. V. Francia, and J. M. G. Lobo, "Nucleotide sequence of the ampC-ampR region from the chromosome of Yersinia enterocolitica, " Antimicrobial Agents and Chemotherapy, vol. 36, no. 5, pp. 1049-1052, 1992.
35. L. D. Sabath, M. Jago, and E. P. Abraham, "Cephalosporinase and penicillinase activities of a beta-lactamase from Pseudomonas pyocyanea., " Biochemical Journal, vol. 96, no. 3, pp. 739-752, 1965.
36. C. Michaux, J. Massant, F. Kerff et al., "Crystal structure of a cold-adapted class C-lactamase, " FEBS Journal, vol. 275, no. 8, pp. 1687-1697, 2008.
37. G. Feller, Z. Zekhnini, J. Lamotte-Brasseur, and C. Gerday, "Enzymes from cold-adapted microorganisms. The class C-lactamase from the antarctic psychrophile Psychrobacter immobilis A5, " European Journal of Biochemistry, vol. 244, no. 1, pp. 186-191, 1997.
38. W. E. Farrar Jr. And N. M. O'Dell, "-Lactamase activity in Chromobacteriumviolaceum, "The Journal of InfectiousDiseases, vol. 134, no. 3, pp. 290-293, 1976.
39. A. Bauernfeind, S. Schweighart, and Y. Chong, "Extended broad spectrum-lactamase in Klebsiella pneumoniae including resistance to cephamycins, " Infection, vol. 17, no. 5, pp. 316-321, 1989.
40. A. Bauernfeind, I. Stemplinger, R. Jungwirth, R. Wilhelm, andY. Chong, "Comparative characterization of the cephamycinase bla(CMY-1) gene and its relationship with other-lactamase genes, " Antimicrobial Agents and Chemotherapy, vol. 40, no. 8, pp. 1926-1930, 1996.
41. A. Bauernfeind, I. Stemplinger, R. Jungwirth, and H. Giamarellou, "Characterization of the plasmidic-lactamase CMY-2, which is responsible for cephamycin resistance, " Antimicrobial Agents and Chemotherapy, vol. 40, no. 1, pp. 221-224, 1996.
42. G. A. Jacoby and J. Tran, "Sequence of the MIR-1-lactamase gene, " Antimicrobial Agents and Chemotherapy, vol. 43, no. 7, pp. 1759-1760, 1999.
43. T. Horii, Y. Arakawa, M. Ohta, S. Ichiyama, R. Wacharotayankun, and N. Kato, "Plasmid-mediated AmpC-type-lactamase isolated from Klebsiella pneumoniae confers resistance to broad-spectrum-lactams, including moxalactam, " Antimicrobial Agents and Chemotherapy, vol. 37, no. 5, pp. 984-990, 1993.
44. M. G. Leiza, J. C. Perez-Diaz, J. Ayala et al., "Gene sequence and biochemical characterization of FOX-1 from Klebsiella pneumoniae, a newAmpC-type plasmid-mediated-lactamase with two molecular variants, " Antimicrobial Agents and Chemotherapy, vol. 38, no. 9, pp. 2150-2157, 1994.
45. O. Gaillot, C. Clément, M. Simonet, and A. Philippon, "Novel transferable-lactam resistance with cephalosporinase characteristics in Salmonella enteritidis, " Journal of Antimicrobial Chemotherapy, vol. 39, no. 1, pp. 85-87, 1997.
46. P. A. Bradford, C. Urban, N. Mariano, S. J. Projan, J. J. Rahal, and K. Bush, "Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC-lactamase, and the loss of an outermembrane protein, " Antimicrobial Agents and Chemotherapy, vol. 41, no. 3, pp. 563-569, 1997.
47. A. Bauernfeind, I. Schneider, R. Jungwirth, H. Sahly, and U. Ullmann, "A novel type of AmpC-lactamase, ACC-1, produced by a Klebsiella pneumoniae strain causing nosocomial pneumonia, " Antimicrobial Agents and Chemotherapy, vol. 43, no. 8, pp. 1924-1931, 1999.
48. D. Girlich, T. Naas, S. Bellais, L. Poirel, A. Karim, and P. Nordmann, "Biochemical-genetic characterization and regulation of expression of an ACC-1-like chromosome-borne cephalosporinase from Hafnia alvei, " Antimicrobial Agents and Chemotherapy, vol. 44, no. 6, pp. 1470-1478, 2000.
49. R. Nakano, R. Okamoto, Y. Nakano et al., "CFE-1, a Novel Plasmid-Encoded AmpC-Lactamase with an ampR Gene Originating from Citrobacter freundii, " Antimicrobial Agents and Chemotherapy, vol. 48, no. 4, pp. 1151-1158, 2004.
50. S. C. Parija, Textbook of Microbiology & Immunology, Elsevier Health Sciences, 2014.
51. A. Zapun, C. Contreras-Martel, and T. Vernet, "Penicillinbinding proteins and-lactam resistance, " FEMS Microbiology Reviews, vol. 32, no. 2, pp. 361-385, 2008.
52. I. Massova and S. Mobashery, "Kinship and diversification of bacterial penicillin-binding proteins and-lactamases, " Antimicrobial Agents and Chemotherapy, vol. 42, no. 1, pp. 1-17, 1998.
53. A. Fedarovich, R. A. Nicholas, and C. Davies, "The role of the 5-11 loop in the active-site dynamics of acylated penicillinbinding protein A from Mycobacterium tuberculosis, " Journal of Molecular Biology, vol. 418, no. 5, pp. 316-330, 2012.
54. A. H. Delcour, "Outer membrane permeability and antibiotic resistance, " Biochimica et Biophysica Acta-Proteins and Proteomics, vol. 1794, no. 5, pp. 808-816, 2009.
55. X. Z. Li and H. Nikaido, "Efflux-mediated drug resistance in bacteria: An update, " Drugs, vol. 69, no. 12, pp. 1555-1623, 2009.
56. K. Bush and G. A. Jacoby, "Updated functional classification of-lactamases, " Antimicrobial Agents and Chemotherapy, vol. 54, no. 3, pp. 969-976, 2010.
57. J. D. D. Pitout, "Infections with extended-spectrum betalactamase-producing enterobacteriaceae: changing epidemiology and drug treatment choices, " Drugs, vol. 70, no. 3, pp. 313-333, 2010.
58. R. P. Ambler, A. F. W. Coulson, J.-M. Frere et al., "A standard numbering scheme for the class A-lactamases, " Biochemical Journal, vol. 276, no. 1, pp. 269-270, 1991.
59. G. A. Jacoby, "AmpC-lactamases, " Clinical Microbiology Reviews, vol. 22, no. 1, pp. 161-182, 2009.
60. K. L. Chew, R. T. Lin, and J. W. Teo, "Klebsiella pneumoniae in Singapore: hypervirulent infections and the carbapenemase threat, " Frontiers in Cellular and Infection Microbiology, vol. 7, 2017.
61. J. C. Cho, M. A. Fiorenza, and S. J. Estrada, "Ceftolozane/ tazobactam: A novel cephalosporin/-lactamase inhibitor combination, " Pharmacotherapy, vol. 35, no. 7, pp. 701-715, 2015.
62. E. Geisinger and R. R. Isberg, "Interplay between antibiotic resistance and virulence during disease promoted by multidrug-resistant bacteria, " The Journal of Infectious Diseases, vol. 215, no. 1, pp. S9-S17, 2017.
63. R. A. Powers, "Structural and functional aspects of extendedspectrum ampc cephalosporinases, " Current Drug Targets, vol. 17, no. 9, pp. 1051-1060, 2016.
64. A. M. Queenan, B. Foleno, C. Gownley, E. Wira, and K. Bush, "Effects of inoculum and-Lactamase activity in AmpC-and extended-Spectrum-Lactamase (ESBL)-producing escherichia coli and klebsiella pneumoniae clinical isolates tested by using NCCLS ESBL methodology, " Journal of Clinical Microbiology, vol. 42, no. 1, pp. 269-275, 2004.
65. W.-H. Zhao and Z.-Q. Hu, "Epidemiology and genetics of CTXM extended-spectrum-lactamases in Gram-negative bacteria, " Critical Reviews in Microbiology, vol. 39, no. 1, pp. 79-101, 2013.
66. R. Cantón, J. M. González-Alba, and J. C. Galán, "CTX-M enzymes: origin and diffusion, " Frontiers in Microbiology, vol. 3, 2012.
67. A. Birbrair and P. S. Frenette, "Niche heterogeneity in the bone marrow, " Annals of the New York Academy of Sciences, vol. 1370, no. 1, pp. 82-96, 2016.
68. M. M. D'Andrea, F. Arena, L. Pallecchi, and G. M. Rossolini, "CTX-M-type-lactamases: A successful story of antibiotic resistance, " International Journal of Medical Microbiology, vol. 303, no. 6-7, pp. 305-317, 2013.
69. S. B. Levy, "Factors impacting on the problem of antibiotic resistance, " Journal of Antimicrobial Chemotherapy, vol. 49, no. 1, pp. 25-30, 2002.
70. A. Oliver, J. C. Pérez-Daz, T. M. Coque, F. Baquero, and R. Cantón, "Nucleotide sequence and characterization of a novel cefotaxime-hydrolyzing-lactamase (CTX-M-10) isolated in Spain, " Antimicrobial Agents and Chemotherapy, vol. 45, no. 2, pp. 616-620, 2001.
71. A. Karim, L. Poirel, S. Nagarajan, and P. Nordmann, "Plasmidmediated extended-spectrum-lactamase (CTX-M-3 like) from India and gene association with insertion sequence ISEcp1, " FEMSMicrobiology Letters, vol. 201, no. 2, pp. 237-241, 2001.
72. L. B. Rice, S. H. Willey, G. A. Papanicolaou et al., "Outbreak of ceftazidime resistance caused by extended-spectrum-lactamases at a Massachusetts chronic-care facility, " Antimicrobial Agents and Chemotherapy, vol. 34, no. 11, pp. 2193-2199, 1990.
73. C. D. Steward, D. Wallace, S. K. Hubert et al., "Ability of laboratories to detect emerging antimicrobial resistance in nosocomial pathogens: A survey of Project ICARE laboratories, " DiagnosticMicrobiology and Infectious Disease, vol. 38, no. 1, pp. 59-67, 2000.
74. R. Alsterlund, B. Carlsson, L. Gezelius, S. Hæggman, and B. Olsson-Liljequist, "Multiresistant CTX-M-15 ESBL-producing Escherichia coli in southern Sweden: description of an outbreak, " Infectious Diseases, vol. 41, no. 6-7, pp. 410-415, 2009.
75. M. F. Vázquez, J. L. Muñoz Bellido, M. I. Garca Garca, and J. A. Garca-Rodrguez, "Salmonella enterica serovar Enteritidis producing a TEM-52-lactamase: first report in Spain, " Diagnostic Microbiology and Infectious Disease, vol. 55, no. 3, pp. 245-246, 2006.
76. L. P. Randall, C. Clouting, R. A. Horton et al., "Prevalence of Escherichia coli carrying extended-spectrum-lactamases (CTX-M and TEM-52) from broiler chickens and turkeys in Great Britain between 2006 and 2009, " Journal of Antimicrobial Chemotherapy, vol. 66, no. 1, Article IDdkq396, pp. 86-95, 2011.
77. M. Perilli, B. Segatore, C. Mugnaioli et al., "Persistence of TEM-52/TEM-92 and SHV-12 extended-spectrum-lactamases in clinical isolates of enterobacteriaceae in Italy, " Microbial Drug Resistance, vol. 17, no. 4, pp. 521-524, 2011.
78. P. F. Harrison and J. Lederberg, Antimicrobial Resistance: Issues and Options, National Academies Press, 1998.
79. S. B. Levy, "Antibiotic resistance: consequences of inaction, " Clinical InfectiousDiseases, vol. 33, supplement 3, pp. S124-S129, 2001.
80. L. Jostins, S. Ripke, R. K. Weersma et al., "Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease, " in Nature, vol. 491, pp. 119-124, 119-124, 2012.
81. R. Cantón, A. Novais, A. Valverde et al., "Prevalence and spread of extended-spectrum-lactamase-producing Enterobacteriaceae in Europe, " Clinical Microbiology and Infection, vol. 14, supplement 1, pp. 144-153, 2008.
82. T. M. Coque, â. Novais, A. Carattoli et al., "Dissemination of clonally related Escherichia coli strains expressing extendedspectrum-lactamase CTX-M-15, " Emerging Infectious Diseases, vol. 14, no. 2, pp. 195-200, 2008.
83. R. Cantón and T. M. Coque, "The CTX-M-lactamase pandemic, " Current Opinion in Microbiology, vol. 9, no. 5, pp. 466-475, 2006.
84. M. H. M. Al-Agamy, M. S. E.-D. Ashour, and I. Wiegand, "First description of CTX-M-lactamase-producing clinical Escherichia coli isolates from Egypt, " International Journal of Antimicrobial Agents, vol. 27, no. 6, pp. 545-548, 2006.
85. A. F. Tawfik, A. M. Alswailem, A. M. Shibl, and M. H. M. Al-Agamy, "Prevalence and genetic characteristics of TEM, SHV, and CTX-M in clinical Klebsiella pneumoniae isolates from Saudi Arabia, " Microbial Drug Resistance, vol. 17, no. 3, pp. 383-388, 2011.
86. H. S. Khanfar, K. M. Bindayna, A. C. Senok, and G. A. Botta, "Extended spectrum beta-lactamases (ESBL) in Escherichiacoli and Klebsiella pneumoniae: Trends in the hospital and community settings, " The Journal of Infection in Developing Countries, vol. 3, no. 4, pp. 295-299, 2009.
87. T. Yagi, H. Kurokawa, N. Shibata, K. Shibayama, and Y. Arakawa, "A preliminary survey of extended-spectrum-lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Japan, " FEMS Microbiology Letters, vol. 184, no. 1, pp. 53-56, 2000.
88. N. H. Ryoo, E.-C. Kim, S. G. Hong et al., "Dissemination of SHV-12 and CTX-M-type extended-spectrum-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea, " Journal of Antimicrobial Chemotherapy, vol. 56, no. 4, pp. 698-702, 2005.
89. C. J. Munday, J. Xiong, C. Li, D. Shen, and P. M. Hawkey, "Dissemination of CTX-M type-lactamases in Enterobacteriaceae isolates in the People's Republic of China, " International Journal of Antimicrobial Agents, vol. 23, no. 2, pp. 175-180, 2004.
90. T. Ali, S. Ur Rahman, L. Zhang et al., "ESBL-producing Escherichia coli from cows suffering mastitis in China contain clinical class 1 integronswithCTX-M linked to ISCR1, " Frontiers in Microbiology, vol. 7, article no. 1931, 2016.
91. T. Ali, S. Ur Rahman, L. Zhang et al., "Characteristics and genetic diversity of multi-drug resistant extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli isolated from bovine mastitis, " Oncotarget, vol. 8, no. 52, pp. 90144-90163, 2017.
92. D. Mathai, P. R. Rhomberg, D. J. Biedenbach et al., "Evaluation of the in vitro activity of six broad-spectrum-lactam antimicrobial agents tested against recent clinical isolates from India: A survey of ten medical center laboratories, " Diagnostic Microbiology and Infectious Disease, vol. 44, no. 4, pp. 367-377, 2002.
93. K. Jabeen, A. Zafar, and R. Hasan, "Frequency and sensitivity pattern of extended spectrum beta lactamase producing isolates in a tertiary care hospital laboratory of Pakistan, " Journal of the Pakistan Medical Association, vol. 55, no. 10, pp. 436-439, 2005.
94. Y. Hirakata, J. Matsuda, Y. Miyazaki et al., "Regional variation in the prevalence of extended-spectrum-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002), " Diagnostic Microbiology and Infectious Disease, vol. 52, no. 4, pp. 323-329, 2005.
95. M. Adnan, H. Khan, J. Kashif et al., "Clonal expansion of sulfonamide resistant Escherichia coli isolates recovered from diarrheic calves, " Pakistan Veterinary Journal, vol. 37, no. 2, pp. 230-232, 2017.
96. U. Naseer and A. Sundsfjord, "The CTX-M conundrum: dissemination of plasmids and Escherichia coli clones, " Microbial Drug Resistance, vol. 17, no. 1, pp. 83-97, 2011.
97. D. Mazel, "Integrons: Agents of bacterial evolution, " Nature Reviews Microbiology, vol. 4, no. 8, pp. 608-620, 2006.
98. G. Peirano, A. K. Van Der Bij, D. B. Gregson, and J. D. D. Pitout, "Molecular epidemiology over an 11-year period (2000 to 2010) of extended-spectrum-lactamase-producing Escherichia coli causing bacteremia in a centralized Canadian region, " Journal of Clinical Microbiology, vol. 50, no. 2, pp. 294-299, 2012.
99. F. Hayes, "Toxins-antitoxins: plasmid maintenance, programmed cell death, and cell cycle arrest, " Science, vol. 301, no. 5639, pp. 1496-1499, 2003.
100. M. D. Tamang, H.-M. Nam, M. Gurung et al., "Molecular characterization of CTX-M-lactamase and associated addiction systems in Escherichia coli circulating among cattle, farmworkers, and the farm environment, " Applied and Environmental Microbiology, vol. 79, no. 13, pp. 3898-3905, 2013.